SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    L. G. Sylvia, N. A. Reilly-Harrington, A. C. Leon, C. I. Kansky, J. R. Calabrese, C. L. Bowden, T. A. Ketter, E. S. Friedman, D. V. Iosifescu, M. E. Thase, M. J. Ostacher, M. Keyes, D. Rabideau, A. A. Nierenberg, Medication adherence in a comparative effectiveness trial for bipolar disorder, Acta Psychiatrica Scandinavica, 2014, 129, 5
  2. 2
    P. S. V. N. Sharma, Sreejayan Kongasseri, Samir Kumar Praharaj, Outcome of Mood Stabilizer Discontinuation in Bipolar Disorder After 5 Years of Euthymia, Journal of Clinical Psychopharmacology, 2014, 34, 4, 504

    CrossRef

  3. 3
    Gin S. Malhi, Michelle Tanious, Pritha Das, Carissa M. Coulston, Michael Berk, Potential Mechanisms of Action of Lithium in Bipolar Disorder, CNS Drugs, 2013, 27, 2, 135

    CrossRef

  4. 4
    Robert K. McNamara, Jeffrey R. Strawn, Role of long-chain omega-3 fatty acids in psychiatric practice, PharmaNutrition, 2013, 1, 2, 41

    CrossRef

  5. 5
    Seena Fazel, Achim Wolf, John R Geddes, Suicide in prisoners with bipolar disorder and other psychiatric disorders: a systematic review, Bipolar Disorders, 2013, 15, 5
  6. 6
    ANDREW W. DONOHUE, Diagnosing Bipolar Disorder in the Community Setting, Journal of Psychiatric Practice, 2012, 18, 6, 395

    CrossRef

  7. 7
    Alexandre Duarte Gigante, Beny Lafer, Lakshmi N. Yatham, Long-Acting Injectable Antipsychotics for the Maintenance Treatment of Bipolar Disorder, CNS Drugs, 2012, 26, 5, 403

    CrossRef

  8. 8
    Joseph F Goldberg, Martin Harrow, A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression, Bipolar Disorders, 2011, 13, 2
  9. 9
    Gin S. Malhi, Michelle Tanious, Optimal Frequency of Lithium Administration in the Treatment of Bipolar Disorder, CNS Drugs, 2011, 25, 4, 289

    CrossRef

  10. 10
    Stefan De Hert, Georgina Imberger, John Carlisle, Pierre Diemunsch, Gerhard Fritsch, Iain Moppett, Maurizio Solca, Sven Staender, Frank Wappler, Andrew Smith, Preoperative evaluation of the adult patient undergoing non-cardiac surgery, European Journal of Anaesthesiology, 2011, 28, 10, 684

    CrossRef

  11. 11
    Paul A. Vöhringer, S. Nassir Ghaemi, Solving the Antidepressant Efficacy Question: Effect Sizes in Major Depressive Disorder, Clinical Therapeutics, 2011, 33, 12, B49

    CrossRef

  12. 12
    Lesley Berk, Karen T. Hallam, Francesc Colom, Eduard Vieta, Melissa Hasty, Craig Macneil, Michael Berk, Enhancing medication adherence in patients with bipolar disorder, Human Psychopharmacology: Clinical and Experimental, 2010, 25, 1
  13. 13
    Halldóra Jónsdóttir, Stein Opjordsmoen, Astrid B. Birkenaes, John A. Engh, Petter Andreas Ringen, Anja Vaskinn, Trond O. Aamo, Svein Friis, Ole A. Andreassen, Medication Adherence in Outpatients With Severe Mental Disorders, Journal of Clinical Psychopharmacology, 2010, 30, 2, 169

    CrossRef

  14. 14
    Arash Ansari, David N. Osser, The Psychopharmacology Algorithm Project at the Harvard South Shore Program, Harvard Review of Psychiatry, 2010, 18, 1, 36

    CrossRef

  15. 15
    Richard C. Shelton, Olawale Osuntokun, Alexandra N. Heinloth, Sara A. Corya, Therapeutic Options for Treatment-Resistant Depression, CNS Drugs, 2010, 24, 2, 131

    CrossRef

  16. 16
    Robert K. McNamara, Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: Current status, future directions, and dietary recommendations, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2009, 81, 2-3, 223

    CrossRef

  17. 17
    The Maudsley Prescribing Guidelines, Tenth Edition, 2009,

    CrossRef

  18. 18
    Matthew G Biel, Eric Peselow, Loretta Mulcare, Brady G Case, Ron Fieve, Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study, Bipolar Disorders, 2007, 9, 5
  19. 19
    Ingeborg Wilting, Frank de Vries, Brahm M.K.S. Thio, Cyrus Cooper, Eibert R. Heerdink, Hubert G.M. Leufkens, Willem A. Nolen, Antoine C.G. Egberts, Tjeerd P. van Staa, Lithium use and the risk of fractures, Bone, 2007, 40, 5, 1252

    CrossRef

  20. 20
    Robert K. McNamara, Michelle Ostrander, William Abplanalp, Neil M. Richtand, Stephen C. Benoit, Debbie J. Clegg, Modulation of phosphoinositide–protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2006, 75, 4-5, 237

    CrossRef

  21. 21
    Ana Gonzalez-Pinto, Fernando Mosquera, Marta Alonso, Purificación López, Fernando Ramírez, Eduard Vieta, Ross J Baldessarini, Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment, Bipolar Disorders, 2006, 8, 5p2
  22. 22
    Joanna Moncrieff, Why is it so difficult to stop psychiatric drug treatment?, Medical Hypotheses, 2006, 67, 3, 517

    CrossRef

  23. 23
    Luc De Baerdemaeker, Kurt Audenaert, Kathelijne Peremans, Anaesthesia for patients with mood disorders, Current Opinion in Anaesthesiology, 2005, 18, 3, 333

    CrossRef

  24. 24
    G. S. Malhi, P. B. Mitchell, M. Berk, G. M. Goodwin, Mood stabilizers: a labile label, Acta Psychiatrica Scandinavica, 2005, 111,
  25. 25
    Charles L Bowden, Michelle A Collins, Susan L McElroy, Joseph R Calabrese, Alan C Swann, Richard H Weisler, Patricia J Wozniak, Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo, Neuropsychopharmacology, 2005, 30, 10, 1932

    CrossRef

  26. 26
    Joanna Moncrieff, David Cohen, Rethinking Models of Psychotropic Drug Action, Psychotherapy and Psychosomatics, 2005, 74, 3, 145

    CrossRef

  27. 27
    F Colom, E Vieta, J Sánchez-Moreno, A Martínez-Arán, M Reinares, JM Goikolea, J Scott, Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels, Bipolar Disorders, 2005, 7,
  28. 28
    The Maudsley 2005-2006 Prescribing Guidelines, 2005,

    CrossRef

  29. 29
    Daniel Z. Lieberman, Frederick K. Goodwin, Separate and concomitant use of lamotrigine, lithium, and divalproex in bipolar disorders, Current Psychiatry Reports, 2004, 6, 6, 459

    CrossRef

  30. 30
    Glenda MacQueen, Russel T. Joffe, The clinical effects of lithium discontinuation: the debate continues, Acta Psychiatrica Scandinavica, 2004, 109, 2
  31. 31
    Robert M. Post, The status of the sensitization/kindling hypothesis of bipolar disorder, Current Psychosis & Therapeutics Reports, 2004, 2, 4, 135

    CrossRef

  32. 32
    Michael O'Kelly, Bohdana Ratitch, Analyses under Missing-not-at-random Assumptions,
  33. 33
    Bibliography,